Robert Weingarten - Guardion Health Independent Secretary
| GHSIDelisted Stock | USD 3.29 0.04 1.23% |
Executive
Robert Weingarten is Independent Secretary of Guardion Health Sciences
| Age | 72 |
| Phone | 800 873 5141 |
| Web | https://www.guardionhealth.com |
Robert Weingarten Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Weingarten against Guardion Health pink sheet is an integral part of due diligence when investing in Guardion Health. Robert Weingarten insider activity provides valuable insight into whether Guardion Health is net buyers or sellers over its current business cycle. Note, Guardion Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Guardion Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Weingarten over six months ago Acquisition by Robert Weingarten of 200000 shares of Lixte Biotechnology subject to Rule 16b-3 |
Guardion Health Management Efficiency
The company has return on total asset (ROA) of (0.1553) % which means that it has lost $0.1553 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5026) %, meaning that it created substantial loss on money invested by shareholders. Guardion Health's management efficiency ratios could be used to measure how well Guardion Health manages its routine affairs as well as how well it operates its assets and liabilities.Guardion Health Sciences currently holds 3.77 M in liabilities. Guardion Health Sciences has a current ratio of 11.05, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Guardion Health until it has trouble settling it off, either with new capital or with free cash flow. So, Guardion Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Guardion Health Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Guardion to invest in growth at high rates of return. When we think about Guardion Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Uri Birenberg | Im Cannabis Corp | 48 | |
| Cassie Jung | Aquestive Therapeutics | 45 | |
| Steve Laninga | Lifecore Biomedical | N/A | |
| Ernest Toth | Aquestive Therapeutics | 65 | |
| Jon MBA | Biofrontera | N/A | |
| Huang CFA | China Pharma Holdings | N/A | |
| Robert Cavorsi | Organogenesis Holdings | 45 | |
| Robert Arnold | Aquestive Therapeutics | N/A | |
| Richard Balla | Im Cannabis Corp | N/A | |
| Alycia Torres | Biofrontera | N/A | |
| Matt Augustson | Lifecore Biomedical | N/A | |
| DMD MD | Evoke Pharma | 76 | |
| Brikkelle Thompson | Lifecore Biomedical | N/A | |
| Sherry Korczynski | Aquestive Therapeutics | N/A | |
| Karen FFPM | Cyclo Therapeutics | N/A | |
| Michael Lisjak | Cyclo Therapeutics | 50 | |
| Kenneth Marshall | Aquestive Therapeutics | 65 | |
| Marilyn Carlson | Evoke Pharma | 76 | |
| Mark CPA | Evoke Pharma | 47 | |
| Timothy CPA | Shuttle Pharmaceuticals | 66 | |
| MBA MD | Aquestive Therapeutics | 66 | |
Management Performance
| Return On Equity | -0.5 | |||
| Return On Asset | -0.16 |
Guardion Health Sciences Leadership Team
Elected by the shareholders, the Guardion Health's board of directors comprises two types of representatives: Guardion Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guardion. The board's role is to monitor Guardion Health's management team and ensure that shareholders' interests are well served. Guardion Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guardion Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Weingarten, Independent Secretary | ||
| Janet Hall, President CEO | ||
| Jeffrey Benjamin, Chief Officer | ||
| Craig Sheehan, Chief Officer | ||
| Bret Scholtes, CEO Pres | ||
| Katie Cox, Chief Officer |
Guardion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Guardion Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | 0.52 % | |||
| Operating Margin | (18.75) % | |||
| Current Valuation | (987.33 K) | |||
| Shares Outstanding | 1.35 M | |||
| Shares Owned By Insiders | 1.30 % | |||
| Shares Owned By Institutions | 21.09 % | |||
| Number Of Shares Shorted | 22.26 K | |||
| Price To Earning | (0.71) X |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |